Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C

This case series examines the association between use of hearts from hepatitis C–positive donors for US patients undergoing heart transplant and heart transplant volumes, wait-list duration, the transmission and cure of donor-derived hepatitis C, and morbidity and mortality at 1 year.

Read the full article here

Related Articles